summary of the invention
Packing and the delivery system of a kind of freeze-drying excipient preparation provided by the utility model, comprise freeze-drying excipient preparation, solvent and packing and send packing and the delivery apparatus of described freeze-drying excipient preparation and solvent, it is characterized in that described packing and delivery apparatus are two-chamber blender, wherein solvent and freeze-drying excipient preparation are stored in respectively in the different cavitys of two-chamber blender, and the interaction by each parts of two-chamber blender makes solvent and freeze-drying excipient preparation can immediately mix and derive in use.
The freeze-drying excipient preparation using in the packing of freeze-drying excipient preparation provided by the utility model and delivery system, it is mainly comprised of functional component and adhesive agent, and adhesive agent: functional component=1: 10 to 10: 1.
Described adhesive agent is edible, can does used for cosmetic or pharmaceutically useful a kind of water-soluble high-molecular material, can be polysaccharide, polypeptide, protein, also may be artificial polymerization macromolecule, or through natural macromolecular material or its compound of modification.Conventional adhesive agent includes but not limited to, gelatin class (gelatin, gelatin hydrolysate etc.), cellulose ethers (carboxymethyl cellulose, ethylol methyl textile rope etc.), modified starch series (pulullan, hydroxypropul starch etc.), PVP, PVA, hyalomitome acids, albumin, shitosan and different molecular weight product or their combination etc.
Described functional component can be water-soluble can be also water-fast material, can be for chemicals, bio-pharmaceutical, Chinese medical extract, vitamin, mineral matter, cosmetic beneficiating ingredient and other be to one or more in the useful active component of human body; Can be selected from the composite of following one or more compositions:
Chemicals (active constituents of medicine):
Antipyretic-antalgic anti-inflammatory agent, such as aspirin, Diflunisal, salsalate, paracetamol, Indomethacin, brufen, naproxen, Ketoprofen, pirprofen, suprofen, Flurbiprofen, piroxicam, Meloxicam, Ni Guan Shu Li, Benzbromarone etc.;
Central stimulant, such as pemoline, adrafinil, Piracetam etc.;
Treatment migraine agent, for example Sumatriptan succinate;
Antalgesic, such as rotundin, buprenorphine, pentazocine, naloxone etc.;
Anti-parkinson and treatment senile dementia medicine, for example levodopa, compound carbidopa, compound benserazide, amantadine hydrochloride, piribedil, general sieve phenol amine, donepezil, huperzine are first-class;
Psychotolytic, such as chlorpromazine, fenazil, pethidine, thioridazine, Chlorprothixene, Clozapine, Sulpiride, Tai Bili, penfluridol, Risperidone etc.;
Anti-epileptic disease and anticonvulsive drug, such as dilantin sodium, carbamazepine, Primidone, Gabapentin, Lamotrigine, sodium vedproate, Clonazepam etc.Hypnotic sedative agent, such as diazepam, nitrazepam, Oxazepam, Lorazepam, phenobarbital etc.;
Cholinesterase inhibitor, such as hyoscine etc.;
Antiarrhymic, such as the third pyridine, tocainide, mexiletine, aetmozine, dilantin sodium, Propafenone, amiodarone etc.;
Antianginal and antiatherosclerotic, such as Propranolol, nifedipine, Gemfibrozil, Bezafibrate, Lovastatin, Simvastatin, Pravastatin etc.;
Antihypertensive, such as Enalapril, captopril, Hydrochioro, Amlodipine etc.;
Adrenoreceptor blocking agent, such as acebutolol, alprenolol etc.;
Corticosteroid medicine, such as betamethasone, cortisone acetate etc.;
Antidiabetic, such as Repaglinide etc.;
Antithyroid drug, such as propylthiouracil (PTU), Carbimazole, methimazole etc.;
Antithistamine, such as Cetirizine Hydrochloride, Loratadine etc.;
Autologous active substance, such as dinoprostone, Alprostadil, Betahistine etc.;
Digestive system medication, such as fourth bromine that hyoscyamine, Granisetron Hydrochloride etc.;
Hematological system medicine, such as EPO, cobamamide etc.;
Urinary system medicine, such as azosemide, frusemide etc.;
Reproductive system medicine, such as estrogen, Nandrolone Phenylpropionate etc.;
Antiparasitic agent, such as albendazole, cambendazole etc.;
Antineoplastic, such as aminoglutethimide, amsacrine etc.;
Antimicrobial, such as ampicillin, sulbenicillin disodium etc.;
Tri-Biocin, such as Amoxicillin, cefalexin, Cefprozil, CEFUROXIME AXETIL, Roxithromycin, Erythromycin Ethylsuccinate, josamycin etc.;
Traditional Chinese medicine ingredients:
Effective Component of Chinese Medicine monomer, as: Breviscapinun, qinghaosu etc.;
Single medicinal material material extract and compound Chinese medicine extract, as: tanshinone extract, salvianolic acid extract, composite salvia dropping extract of bolus, cow-bezoar bolus compound extract, ginseng stem and leave general saponin, asiatic moonseed extract, general ginsenoside, Breviscapinun, notoginseng triol-saponin, Glabrous Sarcandra Herb medicinal extract, arasaponin, capillary extract, extractum rhei, andrographolide, hawthorne leaf P.E, asiaticoside etc.;
Natural plant extracts: as aloe extract, yam extract, Bilberry fruit P.E, Bitter Melon P.E, green-tea extract, fucoidin, glabridin, Paeoniflorin etc.;
Bioactive ingredients: EGF, bFGF, aFGF, KGF, IGF, PDGF, VEGF, placenta hydrolyzate, milk extract etc.
Cosmetic beneficiating ingredient: collagen, hyaluronic acid, sodium alginate, aloe extract, general ginsenoside, arasaponin, the yellow extract of people, bamboo lotus water Bulbus Lilii extract, peony extract, EGF, bFGF, aFGF, KGF, IGF, PDGF, VEGF, placenta hydrolyzate, milk extract, various surfactants, algae extract, various vitamin, various beneficial mineral matter, SOD, metallothionein, other raw materials see < < international cosmetic raw material standard Chinese catalogue (version in 2010) > >
Described freeze-drying excipient preparation, it is mainly comprised of functional component, adhesive agent, and needs can add or not add skeleton supporting agent and other auxiliary material (as thickening supensoid agent, antioxidant, flavouring and essence, skin penetration enhancer, pH adjusting agent etc.) according to preparation process.
Described skeleton supporting agent comprises and is not limited to the materials such as the amino acid (as amino acetic acid, alanine, glutamic acid etc.) of sugar (as maltose, trehalose etc.), sugar alcohol (as sweet mellow wine, sorbierite), 2-12 carbon atom and inorganic salts (as sodium phosphate, aluminium silicate etc.).
Other described auxiliary material is including but not limited to thickening supensoid agent, antioxidant, flavouring and essence, skin penetration enhancer, pH adjusting agent etc.; Wherein the mixed earnestly agent of thickening can be selected from the combination of any or they in the natural origin glue classes such as dextran, Arabic gum, xanthans, carragheen, pectin, konjac glucomannan, agar, carbomer, carrageenan and synthetic macromolecular compound and other polypeptide or polysaccharide etc.; Described antioxidant includes but not limited to one or several the compound in the polyhydric phenols of vitamin C and derivant thereof, anthocyanidin, resveratrol, plant origin; Described flavouring and essence include but not limited to the compound of the essence such as mint flavored, chocolate flavoured, vanilla flavored, caf, tea flavour, corn taste, lemon, milk taste or above one or more fragrance; Described skin penetration enhancer include but not limited to lecithin, saponin(e, bay alkyd, any or several the compound in azone, tween, sapn; Described pH adjusting agent includes but not limited to any in citric acid, tartaric acid, carbonate, sodium carbonate, phosphate or several compound.
What in the packing of freeze-drying excipient preparation provided by the utility model and delivery system, use is any device that can realize the utility model object for packing and send packing and the delivery apparatus of described freeze-drying excipient preparation and solvent, is preferably a kind of two-chamber blender.
Described two-chamber blender, comprises that two cavitys (3,6), two pistons (5,7), a bypass (4), a push rod are by hand (10), a discharger (2), discharging lid (1) six part.
Described two cavitys are solid pharmaceutical preparation chamber 3 and liquid preparation chamber 6; Solid pharmaceutical preparation chamber 3 is the cavity near discharger part, and liquid preparation chamber 6 is the cavity away from discharger part; Two parts that it can be separated into by piston for single whole cavity, also can link together and form by two individual cavity, its connection mode comprises the modes such as bonding (welding), non-shape sealed (bonding) or shape sealed (inserting sealed), and it connects and depends on global shape, material and function needs by mode.
Freeze-drying excipient preparation 9 in solid pharmaceutical preparation chamber 3 can be the freeze-drying excipient preparation of various formulas, form, for carry out being distributed into the preparation in solid pharmaceutical preparation chamber 3 after freeze-drying in forming mould; Solvent 8 in liquid preparation chamber 6 can be water, the nutrient solution with certain functional component, Essence and the various solvents that can directly be used in conjunction with freeze-drying excipient.
A described bypass 4, is positioned at side, solid pharmaceutical preparation chamber, and its width is slightly larger than the thickness of piston 5, thereby can make solvent in cavity 6 form opening by piston movement during to bypass 4 place, mixes with the freeze-drying excipient preparation 9 in solid pharmaceutical preparation chamber 3.
A described push rod is pressed hand 10, for exerting pressure to cavity so that the device of piston movement.
A described discharger 2 is any form discharging opening of non-injection needle form, as suction pipe shape, dropper shape, ball shape, the first-class form of spraying.
A described discharging lid 1, is the device of salable discharger mouth, makes chamber substance in vivo and external environment isolation.
The utility model also relates to the preparation method of above-mentioned freeze-drying excipient preparation.
The preparation of described freeze-drying excipient preparation be in forming mould after freeze-drying the demoulding being fitted in the solid pharmaceutical preparation cavity in two-chamber blender pack.Preparation method comprises
(a) functional component, adhesive agent and other auxiliary material are mixed with to solution, emulsion or suspending fluid injection molding; Or by solid functional component injection molding, then add adhesive agent and other auxiliary material wiring solution-forming, emulsion or suspending fluid;
(b) solution (a) being obtained or suspending fluid carry out degassed in quantitative forming mould;
(c) (b) obtained degassed after solution, emulsion or suspending fluid or solution emulsion or the suspending fluid, freezing at low temperatures directly (a) being obtained;
(d) preparation (c) being obtained lyophilisation in quantitative forming mould, except desolventizing, obtain freeze-drying excipient preparation;
(e) the freeze-drying excipient preparation (d) being obtained is detached into mould and packs packing device into or its forming mould is exactly one of them cavity, with this, directly assembles.
Wherein the described injection molding volume of step (a) is 0.01-5.0ml; Wherein injection molding can adopt the liquid-transfering devices such as accurate quantification pipet, liquid-transfering gun, electronic liquor-transferring rifle, also can adopt plunger pump, gear type pump, peristaltic pump etc., and the solution configuring or suspending fluid are injected to quantitative forming mould; Wherein degas method can adopt centrifugal degassing method, vacuum degasification method and ultrasonic degas method etc.; The freezing mode that can adopt liquid nitrogen or liquid, solid carbonic oxide spray refrigeration wherein, turbine expander refrigeration mode or cascade refrigeration mode, at-20 ℃--at 196 ℃ of temperature, rapidly by solution or the freezing solid that becomes of suspending fluid; Wherein freeze-drying adopts the degree of vacuum of 0.01-20 millibar, temperature freeze-drying between-70 ℃ of-50 ℃ of scopes.
The beneficial effects of the utility model are:
1. the stability of prolection composition: by this packing and delivery system, realized solid and liquid separately, high activity material stability is often bad, with solid forms, preserves, its stability improves greatly, can improve result of use, reduce potential side reaction, Shelf-life;
2. unit dose package: compare with many measuring productses of routine, this packing and delivery system are unit dose packages,, its amount of liquid meets aircraft and carries requirement, is easy to carry;
3. avoid polluting: compare with the bottled freeze-dried powder form of traditional double with traditional two aluminium packings of freeze-drying figuration, the all assembling process of this packing and delivery system complete in clean producing tract, do not have exposed component only from discharging opening, to extrude, can not cause the microbial contamination in process for preparation;
4. easy to use: compare with traditional two aluminium packings of freeze-drying figuration, this packing and delivery system, without opening packing, put into the palm, then add liquid, to point the complicated occupation mode of the both hands cooperation mixing, only need one to push away, open two actions of discharging opening and can use, very convenient;
5. reduce costs: compare with freeze-dried powder, there is no complicated two Bottle and bottle cap systems; Compare with traditional two aluminium packings of freeze-drying figuration, there is no complicated support and structure design, full automation packing, significantly reduces production costs;
The specific embodiment
Further illustrate by the following examples the utility model, but the utility model is not restricted to this.
The bottom of the cavity of following examples indication, refers to that cavity is away from the far-end of discharging opening; The top of bypass 4 refers to the one end near discharging opening, and the below of bypass 4 refers to the other end away from discharging opening; The top of piston refers to that piston is near one end of discharging opening, and the bottom of piston refers to that piston is away from the other end of discharging opening.
Embodiment 1:
EGF stoste, after thawing, add gelatin, gelatin hydrolysate, be mixed with EGF (weight ratio), the gelatin+gelatin hydrolysate solution containing 5% containing 5/100000ths, fillingly enter 0.1 milliliter of forming mould, the solid pharmaceutical preparation chamber 3 that packs the two-chamber blender of glass material after freeze-drying moulding into, is then fitted into the piston of quality of rubber materials 53 bottoms, solid pharmaceutical preparation chamber, bypass 4 belows; Again 2 milliliters of 3% hyaluronic acid solutions are filled into the liquid preparation chamber 6 that the piston 5 of quality of rubber materials isolates; The piston 7 that adds afterwards quality of rubber materials, makes that liquid is complete to be stored in liquid preparation chamber 6, can between the piston 5 of quality of rubber materials and the piston 7 of quality of rubber materials, not ooze out, and obtains the two-chamber blender packing device that comprises lyophilized excipient and solvent.
During use, pack a push rod 10 into piston 7, promote push rod 10 6 direction motions to liquid preparation chamber, the interior fluid pressure in liquid preparation chamber 6 drives piston 53 direction motions to solid pharmaceutical preparation chamber; When piston 5 bottom motions surpass bypass 4 below, the interior liquid in liquid preparation chamber 6 is under piston 7 pressure, by bypass 4, directly get around piston 5, enter solid pharmaceutical preparation chamber 3, mix with lyophilized excipient wherein, continue to promote forward push rod to piston 7 tops and contact with piston 5 bottoms, whole liquid preparations chamber 6 hyaluronic acid solutions of interior 2 milliliter 3% mix with lyophilized excipient completely, EGF, 0.25% gelatin+gelatin hydrolysate, 3% hyaluronic solution that formation contains 2.5ppm; Open discharging lid 1, continue to promote push rod 10, drive piston 7 to press piston 5, aforesaid mixed solution is extruded from discharger 2, discharger 2 nose shapes are ball form, in extrusion, can be applied to face by Direct Uniform, become modern biological cosmetics.
Embodiment 2:
Vitamin C: Propiram=5: 1, mixed powder 50mg enters 0.4 milliliter of forming mould so that solid form is filling, then after remaining 10mg being dissolved with 0.4 ml water, fillingly enter to contain powder to forming mould, after freeze-drying, the lyophilized excipient of acquisition is packed in the solid pharmaceutical preparation chamber 3 with the two-chamber blender of the plastic material of bypass 4, then silicon is handed over the piston 5 of material to be fitted into 3 bottoms, solid pharmaceutical preparation chamber, bypass 4 belows of plastic material.
2 milliliters of deionized waters are filled into the liquid preparation chamber 6 of the plastic material that the piston 7 of silica gel material isolates; Afterwards the solid pharmaceutical preparation chamber of plastic material 3 is inserted to the liquid preparation chamber 6 of plastic materials, and with super sonic by two cavity weldings together, the two-chamber blender packing device of the plastic material that obtains comprising lyophilized excipient.
During use, pack a push rod 10 into piston 7, promote push rod 10 6 direction motions to liquid preparation chamber, the interior fluid pressure in liquid preparation chamber 6 drives piston 53 direction motions to solid pharmaceutical preparation chamber; When piston 5 bottom motions surpass bypass 4 below, the interior liquid in liquid preparation chamber 6 is under piston 7 pressure, by bypass 4, directly get around piston 5, enter solid pharmaceutical preparation chamber 3, mix with lyophilized excipient wherein, continue to promote forward push rod to piston 7 tops and contact with piston 5 bottoms, all in liquid preparation chamber 6,2 ml deionized water are mixed with lyophilized excipient completely, form and contain 2.5% ascorbic solution; Open discharging lid 1, continue to promote push rod 10, drive piston 7 to press piston 5, aforesaid mixed solution is extruded from discharger 2, be directly applied to face, become modern cosmetics.
Embodiment 3:
Cordyceps: collagen=1 gram: 5 grams, be mixed with suspension solution, perfusion enters 5 milliliters of forming moulds, after freeze-drying, the lyophilized excipient of acquisition is packed in the solid pharmaceutical preparation chamber 3 with the two-chamber blender of the clad aluminum material of bypass 4, then the piston of butyl rubber material 5 is fitted into clad aluminum material 3 bottoms, solid pharmaceutical preparation chamber, bypass 4 belows.
10 milliliters of the deionized waters that contains natural essence are filled into the liquid preparation chamber 6 of the clad aluminum material that the piston 7 of butyl rubber material isolates; Afterwards the solid pharmaceutical preparation chamber of clad aluminum material 3 is inserted to the liquid preparation chamber 6 of clad aluminum materials, and with high temperature by two cavity weldings together, the two-chamber blender packing device of the clad aluminum material that obtains comprising lyophilized excipient.
During use, pack a push rod 10 into piston 7, promote push rod 10 6 direction motions to liquid preparation chamber, the interior fluid pressure in liquid preparation chamber 6 drives piston 53 direction motions to solid pharmaceutical preparation chamber; When piston 5 bottom motions surpass bypass 4 below, the interior liquid in liquid preparation chamber 6 is under piston 7 pressure, by bypass 4, directly get around piston 5, enter solid pharmaceutical preparation chamber 3, mix with lyophilized excipient wherein, continue to promote forward push rod to piston 7 tops and contact with piston 5 bottoms, all in liquid preparation chamber 6,10 ml deionized water are mixed with lyophilized excipient completely, form the solution that contains Cordyceps and collagen; Open discharging lid 1, continue to promote push rod 10, drive piston 7 to press piston 5, aforesaid mixed solution is extruded from discharger 2, directly oral, become health food.
Embodiment 4:
Arasaponin: PVP=30mmg: 15mmg, be mixed with solution, be filled into 0.3ml forming mould, after freeze-drying, pack the solid pharmaceutical preparation chamber 3 of the two-chamber blender of clad aluminum material into, then the piston of silica gel material 5 is fitted into 3 bottoms, solid pharmaceutical preparation chamber, bypass 4 belows; Again 1 milliliter of large so fragrant sticky deionized water is filled into the liquid preparation chamber 6 that the piston 5 of silica gel material isolates; The piston 7 that adds afterwards silica gel material, makes that liquid is complete to be stored in liquid preparation chamber 6, can between the piston 5 of silica gel material and the piston 7 of silica gel material, not ooze out, and obtains the two-chamber blender packing device that comprises lyophilized excipient.
During use, pack a push rod 10 into piston 7, promote push rod 10 6 direction motions to liquid preparation chamber, the interior fluid pressure in liquid preparation chamber 6 drives piston 53 direction motions to solid pharmaceutical preparation chamber; When piston 5 bottom motions surpass bypass 4 below, the interior liquid in liquid preparation chamber 6 is under piston 7 pressure, by bypass 4, directly get around piston 5, enter solid pharmaceutical preparation chamber 3, mix with lyophilized excipient wherein, continue to promote forward push rod to piston 7 tops with piston 5 bottoms by touching, all in liquid preparations chamber 6,1 ml deionized water is mixed with lyophilized excipient completely, the solution that formation contains 3% arasaponin; Open discharging lid 1, continue to promote push rod 10, drive piston 7 to press piston 5, aforesaid mixed solution is oral by discharging gate 2, form health food.
Embodiment 5:
Bilberry fruit P.E: Propiram=100mg: 15mg, be mixed with solution, perfusion enters 0.5 milliliter of forming mould, packs the solid pharmaceutical preparation chamber 3 of the two-chamber blender of plastic material after freeze-drying into, then the piston of silica gel material 5 is fitted into 3 bottoms, solid pharmaceutical preparation chamber, bypass 4 belows; Again 20 ml deionized water that contain natural colouring matter are filled into the liquid preparation chamber 6 that the piston 5 of silica gel material isolates; The piston 7 that adds afterwards the silica gel material that is connected with push rod 10, makes that liquid is complete to be stored in liquid preparation chamber 6, can between the piston 5 of silica gel material and the piston 7 of silica gel material, not ooze out, and obtains the two-chamber blender packing device that comprises lyophilized excipient.
During use, promote push rod 10 6 direction motions to liquid preparation chamber, the interior fluid pressure in liquid preparation chamber 6 drives piston 53 direction motions to solid pharmaceutical preparation chamber; When piston 5 bottom motions surpass bypass 4 below, the interior liquid in liquid preparation chamber 6 is under piston 7 pressure, by bypass 4, directly get around piston 5, enter solid pharmaceutical preparation chamber 3, mix with lyophilized excipient wherein, continue to promote forward push rod to piston 7 tops and contact with piston 5 bottoms, all the interior 20 milliliters of deionized waters that contain large right pigment in liquid preparation chamber 6 are mixed with lyophilized excipient completely, form the solution that contains 0.5% Bilberry fruit P.E; Open discharging lid 1, continue to promote push rod 10, drive piston 7 to press piston 5, aforesaid mixed solution is oral from discharging gate 2, form solid beverage food.
Packaging structure of the present utility model is not limited to form cited in embodiment, and embodiment is only preferred embodiment of the present utility model, can not limit protection domain with this.All with simple or equivalent variation and modification described in claim scope of the present utility model, all belong to protection domain of the present utility model.